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Bone marrow-derived hematopoietic stem/progenitor cells (HSPCs) encompass a wide array of cell subsets
with different capacities of engraftment and injured tissue-regenerating potential. The characterization/
isolation of the stem cell subpopulations represents a major challenge to improve the efficacy of transplan-
tation protocols used in regenerative medicine. Cystic fibrosis (CF) is one of the diseases whose hope of cure
relies on the successful application of cell-based gene therapy. This study was aimed at characterizing murine
HSPCs on the basis of their bioenergetic competence and CF transmembrane conductance regulator (CFTR)
expression. Positively immunoselected Sca-1 + HSPCs encompassed 2 populations distinguished by their
different size, Sca-1 expression and mitochondrial content. The smaller were the cells, the higher was Sca-1
expression and the lower was the intracellular density of functional mitochondria. Reverse transcription–
polymerase chain reaction and western blotting revealed that HSPCs expressed CFTR mRNA and protein,
which was also functional, as assessed by spectrofluorimetric and patch-clamp techniques. Inhibition of mi-
tochondrial oxidative phosphorylation by oligomycin resulted in a 70% decrease of both the intracelluar
adenosine triphosphate content and CFTR-mediated channel activity. Finally, HSPCs with lower Sca-1 ex-
pression and higher mitochondrial content displayed higher CFTR levels. Our findings identify 2 subpopu-
lations in HSPCs and unveil a so-far unappreciated relationship between bioenergetic metabolism and CFTR
in HSPC biology.
Introduction
Cystic fibrosis (CF) is the most lethal recessive autoso-mal disease in the white population. CF is caused by
mutations in a single gene, the CF transmembrane conduc-
tance regulator (CFTR), a chloride channel expressed on the
apical membrane of epithelial cells [1]. As a consequence, an
impaired secretion/absorption of ions and water ensues in a
number of different organs. Although CF is a multiorgan
disease, the lung pathology is the one mainly responsible for
patient morbidity and mortality. In the airway, the imbal-
anced secretion of chloride combinedwith hyperabsorption of
sodium [due to hyperactivity of the epithelial sodium channel
(ENaC)] determines the formation of dehydrated thick mu-
cus, which is the trigger for bacterial infection and a subse-
quent neutrophil-dominated inflammatory response [2,3].
The hypothesis concerning hyperabsorption of sodium and
fluid from the airways has been recently questioned in the CF
pig model, although CF pigs suffer from airway pathology in
part linked to the inflammation [4].
Despite intensive efforts in finding viable options for CF
gene therapy, CFTR gene transfer in vivo is still too poorly
efficient to be of clinical relevance [5,6]. This has led to a
search for alternative approaches, including the use of stem
cell populations.
This approach would require heterologous or gene cor-
rected autologous stem cells to reach the airways and dif-
ferentiate into epithelial cells. In vivo studies in mouse
models have suggested that bone marrow (BM)-derived he-
matopoietic stem/progenitor cells (HSPCs) can localize to
the lung and acquire phenotypic markers of airway and al-
veolar epithelium, vascular endothelium, and interstitial cells
[7–11]. There is also evidence that blood-borne stem cells
may contribute to lung tissue in recipients of BM or lung
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transplantation [12–14]. However, homing and engraftment
of HSPCs into the lung is a very inefficient process. The
current state of the art indicates that only a very small pro-
portion, that is, < 0.01%–0.025% of lung epithelial cells, is
derived from BM-derived cells (reviewed in [15]). We have
recently demonstrated that in a model mimicking the early
phases of bacterial infection and airway remodeling occur-
ring in CF patients, the local administration of lin- Sca-1+
HSPCs resulted in a limited (*1%) transformation of HSPCs
into respiratory epithelial cells [16]. Although technical
problems can be invocated, it could be that whole BM cells or
selected populations have inherent problems in lung en-
graftment and subsequent transformation into epithelial
cells. The animal model employed and the type of damage
occurring at epithelial level could be another variable.
Primitive hematopoietic stem cells are sequestered in the
BM in the regions with diminished perfusion [17]. It can be
inferred that a hypoxic microenvironment may protect
HSPCs from the toxic and mutagenic effects of free radicals
generated from oxygen. To strengthen these findings, pro-
teomics analysis showed that lin- sca + kit+ HSPCs express
high levels of anerobic glycolytic enzymes and proteins in-
volved in protection against oxidative damage and DNA
repair [18]. Nevertheless, HSPCs have to differentiate and
egress from the BM. They perform this task by migrating
from their endosteal niche toward the central venous sinuses
[19], where they eventually encounter an aerobic environ-
ment. In this study we aimed to characterize subsets of
HSPCs with different bioenergetic potential that might pos-
sibly be utilizable in optimizing stem cell-based tissue-
regenerating protocols. In addition, given the specific interest




All animal procedures were approved and controlled by
the Italian Ministry of Health and carried out according to
the guidelines of the Italian law of protection of animal life.
C57Bl/6 male mice (6–8 weeks old) were sacrificed to obtain
total BM, as previously described [16]. Recovered total BM
cells were filtered (Cell trics 100 mm; Partec), centrifuged,
washed, and re-suspended in an appropriate medium (de-
pending on the negative or positive selection kit used, see
below).
EasySep negative selection
Negative selection of BM stem/progenitor cells by Easy-
Sep (EasySep Mouse Hematopoietic Progenitor Enrichment
Kit; StemCell Technologies) was done accordingly to the
manufacturer’s instructions and as previously described [16].
Phenotypic characterization of lin - cells
About 2· 105 lin - progenitor cells were incubated for
30min at 4C in PBS with a fluorescein isothiocyanate
(FITC)-conjugated anti-Sca-1 antibody (rat anti-mouse
IgG2a; Becton Dickinson; 0.2mg/mL) or FITC-conjugated
isotype control IgG2a (Becton Dickinson; 0.2mg/mL), and
then they were washed 2 times and analyzed by flow cyto-
fluorimetry. The same number of cells was incubated for 1 h
at room temperature with anti-CD45R (rat anti-mouse IgG2a;
Santa Cruz Biotechnology; 4 ng/mL), washed 1 time, and
incubated with an FITC-conjugated secondary antibody
(anti-rat; Santa Cruz; 5 ng/mL) for 45min at room temper-
ature, washed, and analyzed by flow cytometry. Data were
collected using a Coulter Epics XL flow cytometer (Beckman
Coulter) and analyzed with WinMDI 2.9 (www.cyto
.purdue.edu/flowcyt/software/Winmdi.htm).
EasySep positive selection
Positive selection of BM stem/progenitor cells by EasySep
(Mouse Sca1 selection kit; StemCell Technologies) was done
accordingly to the manufacturer’s instructions. Briefly, re-
covered total BM cells were filtered, centrifuged, washed,
and re-suspended in PBS supplemented with 2% FBS, 1mM
EDTA. Subsequently, the Sca-1 phycoerythrin (PE) antibody
was added to isolated BM cells. Then, tetrameric antibody
complex that recognizes both PE and dextran was added,
which was followed by addition of dextran-coated magnetic
nanoparticles. Magnetically labeled target cells were then
separated from unlabeled unwanted cells using the EasySep
magnet by pouring the unlabeled cells off. The vitality of
each HSPC preparation was evaluated by Trypan Blue ex-
clusion assay, which resulted to be 97% – 2% (n = 6).
Analysis of cell cycle and SP cells
About 1· 106 positively selected Sca-1 + HSPCs were re-
suspended in prewarmed PBS containing 2% of FBS and
10mM N-[2-hydroxyethyl]piperzazine-N¢-[2-ethanesulfonic
acid] (HEPES) and added with Hoechst 33342 (Sigma-
Aldrich; 5 mg/mL) and placed at 37C for 90min. To verify
the authenticity of side population (SP) cells we then added
verapamil, the direct inhibitor of the ABC transporter Bcrp1
(also known as Abcg2 murine/ABCG2 human) [20], which
allows the exclusion of the Hoechst 33342 dye. Briefly,
samples were incubated with verapamil (Sigma-Aldrich;
100mM) for 30min at 37C before adding Hoechst 33342. The
tubes containing cells were shaked every 30min. After in-
cubation, the cells were centrifuged at 20,000 g at 4C for
5min, and then the pellet was re-suspended in cold PBS
containing 2% FBS and 10mM HEPES. The tubes were kept
at 4C until cytofluorimetric analysis. Data were collected
and analyzed using a Cell Lab Quanta SC flow cytometer
(Beckman Coulter).
MTG staining
About 2· 105 Sca-1 selected stem/progenitor cells were
added with 500 nM MitoTracker Green (MTG; Invitrogen
Life Technologies) and incubated for 30min at 37C. After 2
washings, the cells were re-suspended in PBS and analyzed
by cytofluorimetry.
Continuous cell lines
Human bronchiolar epithelial cells 16HBE14o- (a gener-
ous gift of Professor D. Gruenert, California Pacific Medical
Center Research Institute, University of California at San
Francisco, CA) were grown as described previously [21].
Human embryonic kidney 293 cells were grown in
IMDM (Sigma-Aldrich) supplemented with 10% FBS and 1%
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glutamine. Murine macrophages M1 (American Type Cul-
ture Collection) were grown in Dulbecco’s modified Eagle’s
medium (Sigma-Aldrich) supplemented with 10% FBS and
1% glutamine.
CFTR cytofluorimetric assay
About 2· 105 Sca-1 selected HSPCs were first fixed in PBS
containing 3% paraformaldehyde and 2% sucrose for 5min,
permeabilized in PBS containing 20mM HEPES, 300mM
sucrose, 50mM NaCl2, 3mM MgCl2, and 0.5% Triton X-100
for 10min, and then were incubated with CFTR antibody
(MAB25031 mouse IgG2a used at 1:500; R&D Systems) for
1 h at 4C, followed by the FITC-conjugated secondary an-
tibody (anti mouse used at 1:1,000; eBioscience) for 45min at
4C, washed 2 times, and analyzed by flow cytofluorimetry.
Controls included the incubation of Sca-1 + HSPCs with the
isotype control antibody FITC rat IgG2a k (clone RTK2758,
Biolegend), used at 1:500, and the secondary antibody only.
16HBE14o - and 293 cells were used as positive and negative
controls for CFTR expression, following the same conditions
of HSPCs.
LSMC analysis
About 3 · 106/mL of either lin - progenitor cells or Sca-1+
HSPCs were incubated with 2mM TetraMethyl-Rhodamine
(TMRE) or 500 nM MTG (30min, 37C), washed with PBS,
fixed with 3.7% paraformaldehyde (5min, room tempera-
ture), resuspended in PBS plus 1% bovine serum albumin,
and incubated with an anti-Sca-1 monoclonal antibody
(30min, 4C). The cells were then washed 3 times with PBS/
bovine serum albumin, pH 7.4, and incubated (1 h, room
temperature) with a secondary FITC- or TRITC-conjugated
antibody. Stained cells were analyzed by a Nikon TE2000
microscope coupled to a Radiance 2100 confocal dual-laser
scanning microscopy system (Bio-Rad). Fluorescent signals
emitted by MTG or FITC-conjugated secondary antibody
(kex, 490 nm; kem, 516nm) and by TMRE or TRITC-conjugated
secondary antibody (kex, 544 nm; kem, 572 nm) were quanti-
fied by LaserSharp and LaserPix software from Bio-Rad.
The specificity of the MTG and TMRE signals was
assessed under uncoupled condition in the presence of
4mM valinomycin plus 10mM carbonyl cyanide m-
chlorophenylhydrazone (CCCP).
Fluorescence chloride efflux measurements
Chloride efflux was measured using the Cl - sensitive dye
MQAE as previously reported [21]. Cells seeded on 0.1%
gelatin-coated glass coverslips were loaded overnight in
culture medium containing 5mM MQAE. Fluorescence was
recorded with a Cary Eclipse Varian spectrofluorometer.
In some experiments the Cl- efflux was detected at the
level of single cells using a video imaging system as previ-
ously reported [22].
All experiments were performed at 37C in HEPES-buffered
bicarbonate-free media [Cl - medium (in mM)]: 135 NaCl, 3
KCl, 1.8 CaCl2, 0.8 MgSO4, 20 HEPES, 1 KH2PO4, 11 glucose,
and Cl - free-medium: 135 NaNO3, 3 KNO3, 0.8 MgSO4, 1
KH2PO4, 20 HEPES, 5 Ca(NO3)2, 11 glucose. The rates of
chloride efflux were calculated by linear regression analysis
of the first 30 points taken at 4 s intervals, whereas the
change of fluorescence was still linear. As in other cell types,
positively selected Sca-1 + HSPCs exhibited a low chloride
efflux under baseline conditions when chloride was replaced
by nitrate. CFTR-dependent chloride efflux was calculated as
the difference in alterations of forskolin (FSK) (10mM) plus
3-isobutyl-1-methylxanthine (IBMX) (500 mM) stimulated
fluorescence in the absence and presence of either of the
CFTR inhibitors glibenclamide (100 mM; Sigma-Aldrich) or
CFTRinh-172 (5 mM; Calbiochem).
Patch clamping
To facilitate adhesion, HSPCs (3· 105) were cultured on
glass coverslips (diameter 12mm) previously coated with
Cell-Tak (BD Biosciences) according to manufacturer’s
adsorption protocol. Cell morphology was not significantly
affected by culturing HSPCs on Cell-Tak. Patch-clamp ex-
periments in cell-attached configuration were performed as
reported [23]. Pipette solutions were optimized for detecting
Cl - currents. In single-channel patches, pipette resistance
was 8–9MO when filled with (in mM): 115 N-methyl-d-
glucamine (NMDG)-Cl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 30
tetraethyl ammonium chloride (TEACl) titrated to pH 7.4.
The bath solution contained (mM): 145 NaCl, 4 KCl, 1 MgCl2,
1 CaCl2, 10 glucose, and 10 HEPES titrated to pH 7.4. Seal
resistance was 15–50 GO. Signals were digitized at a sam-
pling rate 4 kHz, and patch data were analyzed using
Clampfit 9 (Molecular Devices) at a digital filter frequency
of 50Hz. Potential differences were expressed as holding
potentials.
Western blot analysis
Cells were lysed in lysis buffer (110mM NaCl, 50mM
TRIS, 0.5% Triton X-100, and 0.5% Igepal CA-630, pH 8.0
with added protease inhibitor cocktail), sonicated for 10 s,
and centrifuged for 10min (16,000 g).
Forty micrograms of samples was loaded onto 7% sodium
dodecyl sulfate–polyacrylamide gels and then transferred to
polyvinylidene difluoride membranes. Membranes were
probed with anti-hCFTR monoclonal antibody against the C
terminus (MAB25031, dilution 1:500, R&D Systems) and with
anti-b-actin monoclonal antibody (dilution 1:5,000; Sigma-
Aldrich). Immunocomplexes were detected with ECL plus
reagent (Amersham Biosciences). Densitometric analysis of
the stained bands was carried out on digitalized images by the
freeware ImageJ 1.38· (Wayne Rasband, NIH; http://rsb
.info.nih.gpvij/). Endoglycosidase digestion was performed
following protocols provided by the enzyme suppliers. Total
proteins were incubated overnight at 37C with PNGase F
(peptide N-glycosidase F) or endoglycosidase H (both from
Sigma-Aldrich) in the presence of protease inhibitors. The
reaction was terminated by boiling the sample for 5min and
adding Laemmli electrophoresis sample buffer.
RT-PCR and nested PCR
Total RNA was extracted from 1.5 · 105 cells using Trizol
reagent (Invitrogen) following the protocol suggested by the
manufacturer. The concentration of RNA was estimated by
Nanodrop 1000 spectrophotometer (Thermo Scientific) at
260 nm wavelength and the purity was confirmed by mea-
suring the absorbance ratio at 260/280 nm wavelengths.
636 PIRO ET AL.
Total RNA (1 mg) was used to prepare the first-strand
cDNA. The primer used in reverse transcription reaction was
(CFTR reverse) 5¢-TTC CCC AAA TCC CTC CTC-3¢. Reverse
transcription was performed under the following conditions:
initial incubation for 10min at 25C, followed by 120min at
37C and for 25 s at 85C. RNA was reverse transcribed in the
presence of 2.5 units Reverse transcriptase (Applied Biosys-
tems), 0.4 mM of primer, 4mM of nucleotide mix, and com-
mercial buffer (Applied Biosystems).
The primer sets for CFTR-polymerase chain reaction
(PCR) amplification were forward 5¢-CTT TCC AAC AAC
CTG AAC AA-3¢ and reverse 5¢-TTC CCC AAA TCC CTC
CTC-3¢, which produced a DNA segment of 653 bp. PCR was
performed under the following conditions: initial denatur-
ation for 2min at 94C, followed by 35 cycles of denaturation
(15 s, 94C), annealing (30 s, 56C), and extension (1min,
72C).
The primers used in nested CFTR-PCRs were forward int
5¢-CTC TTC TGA TGG GGC TTC T-3¢ and reverse int 5¢-
GGA ACT GCC GTG TGA CTG-3¢, which produced a DNA
segment of 430 bp. PCR was performed under the following
conditions: initial denaturation at 94C for 2min, followed
by 35 cycles of denaturation (15 s, 94C), annealing (30 s,
57C), and extension (1min, 72C). All primers were de-
signed using homologous region for human and mouse
gene. In the PCR, cDNAs (150ng) were used in the presence
of 1 units Taq polymerase (Fermentas), 0.4mM of each pri-
mer (CFTR reverse and forward), 0.2mM of nucleotide mix,
and commercial buffer containing 2mM MgCl2 (Fermentas).
The random primers were used to reverse transcribe the
mRNAs to their corresponding cDNAs. To attest the validity
of extracted cDNAs, we performed the b-actin PCR after
using the following primers: forward 5¢-CAA CTG GGA
CGA CAT GGA–3¢ and reverse 5¢-ACG TCA CAC TTC ATG
ATG GA-3¢, which produced a DNA segment of 610 bp. PCR
was performed under the following conditions: initial de-
naturation for 2min at 94C, followed by 35 cycles of dena-
turation (15 s, 94C), annealing (30 s, 56C), and extension
(1min, 72C). Primers were designed using homologous re-
gion for human and mouse gene. All primers were obtained
from Eurofins MNG Operon.
The identities of amplified products were confirmed by
determination of molecular size on agarose gel electropho-
resis (1.5% agarose in buffer containing 40mM Tris/acetate
and 1mM EDTA) and observed by ethidium bromide
staining (0.5 mg/mL) under ultraviolet light.
ATP assay
Cellular adenosine triphosphate (ATP) content was as-
sayed by bioluminescence using a luciferin–luciferase (rL/L)
reaction system (Enliten ATP assay; Promega), as previously
described [24]. Briefly, 1· 104 HSPCs were centrifuged at
12,000 g for 10min and the surnatant was stored at - 80C.
To lyse the cells, 200mL of boiling ATP-free water was added
to the pellet. After centrifugation at 12,000 g for 5min, 20mL
of sample was added to 100 mL of rL/L reagent and read at
the TD-20/20 luminometer DL-Ready (Turner Design In-
struments) at 560 nm. A standard curve was performed
adding 20mL of ATP standard diluted to the proper con-
centrations at 100mL of rL/L reagent. Oligomycin (8 mg/mL)
was added to 0.4 · 105 HSPCs and the samples were incu-
bated for 2h at 37C, shaken every 30min, and processed as
above.
Data analysis
Data are presented as mean – standard deviation for the
number of samples indicated (n). Statistical comparisons
were made using paired or unpaired data Student’s t-test.
Differences were considered significant when P < 0.05.
Results
Phenotypic characterization of mouse lin -
stem/progenitor cells
The percentage of stem/progenitor in BM cells oscillates
from 0.01% to 0.1% [25,26]. To enrich for HSPCs, a negative
immunoselection method was applied to BM-flushed cells.
The resultant lin - cells were positive for Sca-1 (20.5% – 3.1%;
n= 3) and CD45 (5.3% – 0.5%; n = 3), confirming that the BM
population was enriched for stem/progenitor cells and de-
prived of committed cells. Cytofluorimetric analysis of lin-
cells showed 2 populations distinguishable with respect to
their dimension and density (Supplementary Fig. S1; Sup-
plementary Data are available online at www.liebertonline
.com/scd). The population of larger cells was more positive
to Sca-1 antibody (27%– 0.6%) as compared with the popu-
lation of smaller cells (11.0% – 4.9%, P < 0.05).
Mitochondrial content of lin - cells
Laser scanning confocal microscopy (LSCM) analysis
was carried out to investigate the bioenergetic profile of
BM-derived stem/progenitor cells, purified by negative im-
munoselection. The lypophilic cation TMRE, which accu-
mulates in mitochondria by a membrane potential-driven
process, was used for detection of energized mitochondria. A
representative LSCM analysis is illustrated in Supplementary
Fig. S2A, showing a heterogeneous population of cells with
different size: some of which displayed a high density of
functioning mitochondria, whereas others displayed a fainter
mitochondria-related signal. When the cell sample was pre-
incubated with either the oxidative phosphorylation uncou-
pler CCCP or with potassium cyanide (KCN), no staining by
TMRE was observed (Supplementary Fig. S2A). This verified
both the specificity of the mitochondrial DC probe and its
dependence on the activity of the respiratory chain. Mi-
tochondrial staining was then coupled with immunodetec-
tion of the surface antigen marker of stem cells, Sca-1. As
shown in Supplementary Fig. S2B, the mitochondria-linked
red signal was inversely correlated with the Sca-1 staining
and only 15%–20% of the entire cell population was Sca-1+ ,
confirming cytofluorimetric data.
The mitochondrial content of positively selected
cells inversely correlates with Sca-1 expression
Lin- cells were only 20% enriched for progenitor cells and
displayed a nonhomogeneous content of energized mito-
chondria. These features would not be favorable for en-
graftment into damaged tissues. Thus, it was decided to
carry on this investigation by changing the progenitor cell
selection method. Therefore, whole BM was processed by
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anti-Sca-1-positive selection, which raised the percentage of
stem/progenitor cells to 93%, as shown by cytofluorimetry
(Fig. 1B). Analysis of the cell cycle demonstrated that most of
the cells were in G0/G1 (Supplementary Fig. S3A and B) and
only 0.76%– 0.20% could be identified as side population
(SP) on the basis of their ability to extrude the dye Hoechst
33342 and to be inhibited in this property by incubation with
the drug verapamil (Supplementary Fig. S3C and D). SP cells
comprise a subset (*10%) of the 1% fraction of Sca-1 + lin -
cells from whole BM, thus comprising 0.1% of the BM cells.
Further, the SP cells are enriched about 1,000-fold for HSC
activity, as determined in competitive repopulation experi-
ments, and provide high long-term multilineage contribution
in radioprotection experiments [20].
As for lin- cells, isolated Sca-1+ progenitor cells showed 2
populations distinguishable by their different size and den-
sity (Fig. 1).The mitochondrial content of positively selected
stem/progenitor cells was studied by flow cytofluorimetry
using the fluorescent MTG dye that stains mitochondria in
live cells where its accumulation is driven by the mito-
chondrial membrane potential. We observed that the smaller
the cell was, the higher was the Sca-1 expression and the
lower was the MitoTracker fluorescence intensity (Fig. 2).
The population of larger cells contained a lower percentage
of Sca-1 +MTGlow cells (14.8% – 0.4%) and a higher per-
centage of Sca-1 +MTGhigh (66.5% – 7.7%), whereas the pop-
ulation of smaller cells showed a higher percentage of
Sca-1 +MTGlow (60.3% – 11.9%) and a lower percentage of
Sca-1 +MTGhigh cells (27.6% – 6.5%).
LSCM revealed that almost 95% of the cells were Sca-1+
(confirming flow-cytometry analysis). Sca-1+ HSPCs were
again clearly dishomogeneous for the mitochondrial content
(Fig. 3C). The Sca-1 signal was inversely correlated with the
mitochondrial content, as shown in Fig. 3D, suggesting that
the population is still heterogeneous but the number of cells
with low mitochondria signal and expressing a strong Sca-1
signal has been clearly increased. Pretreatment of Sca-1 +
progenitor cells with the protonophore uncoupler CCCP re-
sulted in a loss of the MTG signal as compared with un-
treated cells (Fig. 3A & B), indicating the specificity of MTG
staining.
CFTR expression in positively selected Sca-1 +
stem/progenitor cells
Since our ultimate goal is a cell-based therapy for CF, we
tested these cells for the presence of CFTR mRNA and pro-
tein. A reverse transcription (RT)–PCR was designed to
amplify either murine or human CFTR by the same set of
primers (see Materials and Methods section). A specific
CFTR band was detected in positive controls M1 murine
macrophages and human bronchiolar epithelial 16HBE14o -
cells, but not in human embryonic kidney 293 cells, that do
not have endogenous CFTR expression [27], nor in HSPCs
(Fig. 4A). A specific CFTR band in HSPCs was detected only
after a nested PCR following the first run PCR (Fig. 4B),
suggesting a very low level of CFTR expression in Sca-1 +
progenitor cells. The identity of murine CFTR was confirmed
by sequencing and comparison to BLAST database (http://
blast.ncbi.nlm.nih.gov/Blast.cgi).
The relatively low expression of CFTRwas confirmed at the
protein level by western blotting analysis (Fig. 5A). Two bands
were immunodetected corresponding to the mature (180 kDa,
band C) and the immature (160 kDa, band B) forms of CFTR,
with the mature peptide being 65% less expressed than in
the 16HBE14o- cells (Fig. 5A). No specific CFTR bands were
FIG. 1. Flow cytometry analysis of
positively selected cells. HSPCs were
analyzed by flow cytometry 30min after
their selection, since the anti-Sca-1 anti-
body used for positive selection was PE-
conjugated. (A) Dot-plot image showing
2 populations distinguishable by their
forward and scatter sides; R1 (the biggest
population) and R2 (the smallest). (B–D)
Histogram plots showing the percentage
of Sca-1 + cells in total population and in
R1 and R2 subsets, respectively. One ex-
periment out of 3, yielding similar re-
sults, is shown. PE, phycoerythrin.
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detected in human embryonic kidney 293 cells. To verify the
identity of bands B and C we used endoglycosidase H and
N-glycosidase F. As expected, while N-glycosidase F reduced
both bands B and C and increased the nonglycosylated form of
CFTR (140 kDa) in both 16HBE41o- cells and HSPCs, en-
doglycosidase H did not exert any effect (Fig. 5B).
CFTR function in positively selected Sca-1 +
stem/progenitor cells
CFTR function in Sca-1+ cells was first assessed by means
of epifluorescence and spectrofluorimetric analyses. In ex-
periments aimed to determine if protein kinase A (PKA)
FIG. 2. Mitochondrial content
of Sca-1+ positively selected
cells. (A) Scatter dot plot of the
whole Sca-1+ population. (B)
Quadrant dot plots of R1 and R2
subpopulations. (C) Schematic
representation showing that the
percentage of positive cells is
correlated to the different regions
of quadrant dot plot. The media
and SD are referred to 3 experi-
ments. MTG, MitoTracker green;
SD, standard deviation.
FIG. 3. Simultaneous staining of
mitochondria and Sca-1 in mouse
BM-derived stem/progenitor cells
isolated by positive immunoselec-
tion. (A) Representative LSCM anal-
ysis of HSPCs stained with MTG. (B)
Specificity of MTG signal in Sca-1 +
HSPCs evaluated by pretreatment
with CCCP. (C) Co-staining
of HSPCs with PE-conjugated anti-
Sca1 mAb and MTG. (D) Quantita-
tive correlation between mitochon-
dria and Sca-1 content. The
mitochondria and Sca-1 fluorescence
signals of about 100 single cells from
10 randomly selected optical fields
were quantified in arbitrary units
(A.U.) by image analyzer software
provided with the confocal micro-
scope (see Materials and Methods
section and ref. [50]) and clustered
(– SD; cells/cluster& 20) every 5–
10A.U. increase of the fluorescence
signal related to the Sca1 antigen. The
analysis shown refers to a single
HSPC preparation but is representa-
tive of 3 different experiments yield-
ing similar results. Bars in A–C,
10mm. BM, bone marrow; LSCM, la-
ser scanning confocal microscopy;
HSPCs, hematopoietic stem/
progenitor cells; CCCP, carbonyl cy-
anide m-chlorophenylhydrazone.
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activation is able to stimulate CFTR-dependent chloride ef-
flux, we performed chloride secretion measurements in both
single cells and in the entire population seeded on glass cov-
erslips using the chloride sensitive dye MQAE, as we have
previously published [21]. To fully activate CFTR channels,
we used forskolin (which activates adenylate cyclase) and
IBMX, which regulates CFTR function by acting both as a
phosphodiesterase and protein phosphatase inhibitor [28] but
also by directly interacting with the NBDs to promote ATP-
dependent channel gating [29]. Figure 6A shows typical re-
cordings obtained by video imaging analysis in 3 Sca-1+
HSPCs demonstrating changes in chloride efflux after the
addition of forskolin and IBMX and the inhibition induced by
the addition of the CFTR inhibitor, glibenclamide. Figure 6B
shows the summary of the data collected from 12 different
murine Sca-1 + cells. The third bar represents CFTR-depen-
dent chloride efflux calculated as the difference in alterations
of stimulated fluorescence in the absence (first bar) and
presence (second bar) of glibenclamide.
A similar pattern of inhibition was obtained using the
specific inhibitor CFTRinh-172 [30] (0.0415– 0.0053 D(F/F0)/
min vs. 0.0192– 0.0018 D(F/F0)/min n = 3, P < 0.01, respec-
tively, in the absence and in the presence of the 5mM
CFTRinh-172).
The CFTR-dependent chloride efflux, as measured in
whole HSPC population, displayed the same features of
that observed in single-cell analysis. Importantly, the level
of CFTR-dependent chloride efflux obtained analyzing the
entire population was similar to that obtained in single
cells (0.0226 – 0.006 D(F/F0)/min, n = 8 vs. 0.0193 – 0.009
D(F/F0)/min, n = 12, n.s.), confirming not only the validity
of our measurements but also the homogeneity of the cell
population.
In addition, we analyzed the CFTR-dependent chloride
efflux in the same experimental conditions in whole cell
populations of the positive control and negative control cell
lines used in the RT-PCR and western blot analyses
(16HBE14o - and 293 cells, respectively). We found that the
CFTR-dependent chloride efflux in the 16HBE14o - cells was
not significantly different from that observed in the whole
HSPC population (0.026 – 0.003 D(F/F0)/min, n= 5, n.s.),
whereas that in the 293 cells was not significantly different
from background (0.0009– 0.0006 D(F/F0)/min, n = 4, n.s.).
Patch clamping of HSPCs
To deepen the knowledge about the properties of the
CFTR Cl- channel in HSPCs and confirm the spectropho-
tometric data, cell-attached patch recordings were carried
out and a channel with mouse CFTR properties was ob-
served (Fig. 7). Representative current tracings are shown in
Fig. 7A before and after the addition of 10 mM forskolin and
2 mM CFTRinh-172. After forskolin exposure, the mean
number of CFTR channels in a patch was 5.0 – 1.1 (n = 7).
Channels exhibited a mean slope conductance, between
0mV and 60mV, of 5.8 – 0.26 pS (n= 7, Fig. 7B), and an open
probability (Po) that was 0.21 – 0.15 (n= 7) after forskolin
addition at - 40mV (Fig. 7C). In particular, the channel Po
was voltage-independent, increased from 0.005– 0.004 (n= 3)
to 0.21 – 0.03 (n = 3) 9min after forskolin exposure, and it was
zeroed 3min after CFTRinh-172 addition. The reversal po-
tential (Erev) was - 36.2 – 3.1mV, well in agreement with a
value consistent with the behavior of a Cl- channel, con-
sidering the depolarized (* - 10mV) membrane potential
reported for hematopoietic cells [31]. These single-channel
properties are similar to those of mouse CFTR expressed in
cortical collecting duct and in CHO cells [32,33].
CFTR channel activity is inhibited by oligomycin
pretreatment
The CFTR is a phosphorylation- and nucleotide-regu-
lated chloride channel. CFTR also directly mediates the
hydrolysis of ATP and this catalytic activity is loosely
coupled to CFTR channel gating [34–37]. To investigate the
functional dependence of CFTR on the cell ATP content,
HSPCs were treated with oligomycin, an inhibitor of the
mitochondrial F0F1 ATP-synthase. Figure 8A and B shows
that inhibition of the mitochondrial oxidative phosphory-
lation caused a 70% reduction of the intracellular ATP
content and a decrease of the CFTR chloride channel ac-
tivity by the same extent.
FIG. 4. Expression of CFTR mRNA in positively selected Sca-
1+ HSPCs. (A) RT-PCR detecting CFTR transcript level in M1
and 16HBE14o- cells 293 cells serve as a negative control. (B)
Nested PCR detecting CFTR transcript level in Sca-1+ , M1, and
16HBE14o- cells, but not in 293 cells. Representative panels of
1 out of 5 experiments are shown. lHindIII marker bands are
shown in the first lane of each gel. CFTR, cystic fibrosis
transmembrane conductance regulator; RT-PCR, reverse tran-
scription–polymerase chain reaction.
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CFTR protein expression in different
Sca-1 + subpopulations
To analyze the CFTR protein expression in the different
subpopulations of positively selected Sca-1+ cells, an im-
munocytofluorimetric assay was performed. As a positive
control, CFTR labeling by the mAb 25031 was assessed in
normal human airway 16HBE14o - cells, resulting in
68.2% – 6.30% of positive cells (Fig. 9A, B; n= 6). Specificity of
the anti-CFTR mAb was assayed in 293 cells, which showed
a positive staining in 2.4% – 0.37% (n = 6; P< 0.0001 as com-
pared with 16HBE14o - by unpaired Student’s t-test). The
entire Sca-1 + population expressed CFTR only in
15.6% – 1.91% of the cells (Fig. 9D). When subpopulations
were analyzed, the biggest (R1) and the smallest (R2) ex-
pressed CFTR in 15.4% – 1.36% and 11.36% – 1.73% of Sca-1+
cells, respectively (Fig. 9E & F). This difference was statisti-
cally significant (P = 0.01; unpaired Student’s t-test).
Discussion
Despite many efforts to isolate a pure hematopoietic pro-
genitor cell population based on patterns of gene expression
in combination with differences in cell size, density, and the
uptake of fluorescence probes such as rhodamine-123, the
resulting cell population remains heterogeneous [38–45]. Our
data confirm this heterogeneity in both lin- Sca-1 + and
positively selected Sca-1+ murine HSPCs. In the attempt to
differentiate hematopoietic progenitor cells on the basis of
their phenotype and mitochondrial content profile, we
identified 2 populations: a population of smaller cells with a
higher percentage of Sca-1+MTGlow cells and a population of
bigger cells containing a lower percentage of Sca-1+MTGhigh
cells. Sca-1 (Ly-6A/E) is a GPI-linked cell surface protein
found on hematopoietic, mammary gland, lung, liver, car-
diac, and mesenchymal stem cells in the mouse [46]. Sca-1
has been shown to be necessary for normal hematopoietic
stem cell activity, as Sca-1 knockout mice have defects in
short-term competitive transplantation and serial transplan-
tation [47]. The homing defect of Sca-1-/- progenitor cells
could be correlated to a decrease in c-kit expression, al-
though self-renewal of Sca-1 -/ - hematopoietic stem cells
appeared to be normal [48]. Since HSPCs loose Sca-1 upon
commitment to myeloid and lymphoid progenitors [49,50],
our data indicate that mitochondrial biogenesis is linked to
and likely required in the first steps of stem/progenitor cell
differentiation [51]. This is substantiated also by the evidence
that primitive hematopoietic stem cells in the BM are se-
questered in a hypoxic microenvironment [17], implying that
low oxygen levels play a fundamental role in the mainte-
nance of normal stem cell function. One of these functions
could be to keep low levels of CFTR expression, as suggested
by the work by Guimbellot et al. [52], who presented evi-
dence that CFTR mRNA, protein, and function are reversibly
depressed by hypoxia in human cultured cells, and that
CFTR mRNA is repressed in murine and human tissues
in vivo. Our data are in good agreement with Spangrude and
Johnson [38], who have shown that hematopoietic stem cells
with higher clonogenic capacity display low-staining with a
mitochondrial fluorescent dye, rhodamine-123. This may
partly be due to cell subset-specific expression of the multi-
drug-resistance 1a/b (MDR1a/b) gene in resting stem cells.
MDR1a/b encodes P-glycoprotein, an ABC transporter that
can efflux this dye [53]. However, low staining of stem/
progenitor cells with TMRE could be likely due to the low
energized status of mitochondria, as previously shown for
FIG. 5. Expression of CFTR protein in
positively selected Sca-1 + HSPCs. (A)
Western blotting of CFTR in Sca-1 + ,
16HBE14o - , and 293 cells. Bands C and B
represent the mature and immature CFTR
polypeptides, respectively. The relative
amount of the CFTR in 16HE14o- , HSPCs,
and 293 cells as assessed by densitometric
analysis and normalized to b-actin, is also
shown (n = 3). Note the absence of both
CFTR forms in 293 cells. (B) Deglycosyla-
tion analysis of the CFTR in 16HBE14o -
and HSPCs. Denatured proteins treated
with endoglycosidase H (Endo H) or N-
glycosidase F (Glyco F) analyzed with 7%
sodium dodecyl sulfate–polyacrylamide gel
electrophoresis. The white arrow indicates
the presence of the nonglycosilated form of
CFTR.
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human HSPCs [51]. This conclusion is supported by the low
number of SP cells (0.76%), which exclude Hoechst 33342
(Supplementary Fig. 3C), an indication of cells expressing
MDR1a/b [25] or, more likely, Abcg2 [54,55].
Bone marrow-derived stem cells may have the capacity to
transdifferentiate and repopulate various organs. Various
groups have attempted to assess if HSPCs can transdiffer-
entiate into airway epithelium [56]. However, in reports that
provided evidence of engraftment and differentiation by
systemic administration of BM-derived stem cells, the fre-
quency in airways is very low (< 1%). We and others [11,16]
have delivered BM cells directly (by intratracheal instillation)
to the lung after lung injury in mice, with results similar to
the systemic administration route. Meanwhile, engraftment
studies have been made also in CF mice. Transplantation of
wild-type cultured stromal marrow cells [57] or whole BM
[58,59] into CF mice resulted in the engraftment of donor-
derived airway epithelial cells in small numbers only (between
0.01% and 0.025%). Interestingly, Bruscia et al. [58,59] found a
partial resumption of the CFTR-mediated chloride currents to
wild-type levels in both gut and nose, although they could not
explain this effect in face of a very low engraftment level.
It has been shown in vitro that only 6% to 20% of CFTR-
expressing cells were required to restore normal levels of
chloride secretory activity in an in vitro epithelium model
[60,61]. However, in vitro and in vivo studies suggest that
nearly every cell in the sample must be corrected with CFTR
to reverse the excess activity of ENaC and possibly have a
therapeutic impact on the hydration of CF lung periciliary
fluid and mucus [60,62,63].
So far extensive studies testing the direct application of
BM-derived stem cells to the CF lung are missing, as those
using different subpopulations.
FIG. 6. Measurements of CFTR-dependent chloride efflux in
single murine hematopoietic stem cells. (A) Typical recordings
showing changes in chloride efflux after PKA stimulation with
FSK (10mM)+ IBMX (500mM) and the inhibition induced by
the addition of the CFTR-specific inhibitor glibenclamide
(100mM) in 3 Sca-1+ HSPCs. To measure the CFTR-dependent
chloride efflux the perfusion medium was changed to a me-
dium in which chloride solution was substituted with an iso-
osmotic nitrate solution. (B) Statistical analysis of data (– SD)
collected from 12 different murine HSPCs. The third bar rep-
resents the CFTR-mediated chloride flux calculated as the dif-
ference in the changes of FSK+ IBMX-stimulated fluorescence
in the absence (first bar) and presence (second bar) of glib-
enclamide (*P< 0.0001 by paired t-test). PKA, protein kinase A;
FSK, forskolin; IBMX, 3-isobutyl-1-methylxanthine.
FIG. 7. Single-channel recording showing CFTR activity in
Sca-1 + selected HSPCs cells in cell-attached configuration.
(A) Example single-channel currents carried by CFTR in the
absence (no FSK), in the presence of 10mM forskolin (FSK) or
in the presence of FSK + 5 mM CFTRinh-172. Numbers on the
right represent the channel closed (0) or open states. (B)Mean
single-channel I–V relationships for CFTR channel at the
presence of 10 mM forskolin (n= 7). (C) Mean single-channel
Po-V relationships for CFTR channel at the presence of 10mM
forskolin (n = 7).
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CFTR expression has already been detected in freshly
isolated BM-derived stem cells. Shu et al. [64] found that
mesenchymal stem cells from adult rats expressed CFTR
mRNA but not protein. Wong and colleagues [65] identified
2 subpopulations in the murine BM as identified by the ex-
pression of Clara cell secretory protein (Ccsp). All Ccsp+
cells expressed CFTR, whereas most Ccsp - cells did not.
Interestingly, more Ccsp + cells were found in naphthalene-
injured airway epithelium compared with Ccsp - cells when
cells were delivered transtracheally to the airways [65]. It is
worth mentioning that both these studies [64,65] investigated
CFTR expression/function after having cultured HSPCs on
permeable filters that allow their transformation into epi-
thelial cells and both found that CFTR was not functional,
whereas our data show that CFTR is active on freshly iso-
lated HSPCs. Overall, these results would imply that in vitro
compartmentalized culture conditions do not give raise to a
well-differentiated epithelia with specialized function such
as ion transport. The limit of our study is that the difference
of functional CFTR expression between the biggest and the
smallest subpopulations was not investigated. Future studies
will be focused on sorting the 2 populations and assaying
their capacity to becoming blood cells or airway epithelial
cells.
Using the same techniques of this article, we previously
showed that also mouse embryonic stem cells show CFTR
channel activity mediating a measurable chloride efflux [22].
Further, the CFTR channel properties measured here re-
semble those observed in differentiated epithelial cells [33],
as shown by patch-clamp experiments. In both hematopoi-
etic and embryonic stem cells, the extent of chloride efflux is
similar to that found in respiratory epithelial cells [21]. Little
is known about the relationship between CFTR gene ex-
pression and the corresponding transport of chloride. En-
dogenous CFTR mRNA appears to be expressed at very low
level. Apparently, 1 to 2 transcripts/cell [61,66] can result in
several hundred CFTR channels/cell, thereby suggesting
that low levels of wt CFTR mRNA expression may be suf-
ficient to determine normal function. Thus, although HSPCs
show lower levels of mRNA and protein than 16HBE14o -
cells, they display a CFTR-dependent chloride efflux similar
to bronchial epithelial cells.
In HSPCs, oligomycin pretreatment determined a decrease
in both ATP intracellular levels and CFTR chloride channel
activity, indicating that CFTR is strictly dependent on mito-
chondrial ATP synthase activity to be fully functional.
Whether this mitochondrial ATP is required for hydrolytic or
nonhydrolytic gating of CFTR, or for activation of CFTR by
PKA, deserves further investigation. Our finding sounds
quite surprising given the generally accepted view that
HSPCs rely for their energetic demand mainly on glycolytic
ATP production and highlights the need to re-evaluate the
FIG. 8. Effect of ATP intracellular depletion on CFTR
chloride channel activity. (A) Sca-1 + -selected HSPCs were
incubated in the presence of oligomycin for 2 h at 37C and
then ATP cellular levels were evaluated. ATP content in
untreated cells were 6.99 – 4.11 mM. Data are expressed as
percentage of untreated cells; n= 4. (B) CFTR channel activity
was evaluated by spectrofluorimetric analysis after 2-h pre-
treatment with oligomycin as described in Fig. 6; n = 3–4;
*P < 0.02 by unpaired t-test). ATP, adenosine triphosphate.
FIG. 9. CFTR expression in HSPC subpopulations.
16HBE14o - cells and Sca-1 + HPSCs were stained with the
anti-CFTR monoclonal antibody against the C terminus of
CFTR (MAB25031) and then analyzed by flow cytometry.
(A) Forward-scatter (FSLN)/side-scatter (SSLN) dot-plot
histogram of 16HBE14o - cells. (B) Histogram showing
16HBE14o - cells stained with anti-CFTR antibody. The
right-sided area in the overlaid cytofluorimetric profile cor-
responds to the expression of CFTR, whereas the left-sided
profile indicates the isotype control for CFTR antibody. (C)
Isotype control for the CFTR antibody in the whole Sca-1 +
population. (D) Staining of the whole population using the
anti-CFTR antibody. (E) Staining for CFTR in the biggest R1
subpopulation. (F) Staining for CFTR in the smallest R2
subpopulation. n = 3. The percentages of double Sca-1PE +/
CFTR fluorescein isothiocyanate + HSPCs are shown in the
upper right quadrant.
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role of mitochondrial bioenergetics in the stem cell homeo-
stasis, as recently reported [67].
In a recent study, Adams et al. showed that HSPCs de-
pend on the Gas-mediated signaling to engraft BM [68].
HSPCs from adult Gas
-/- mice were able to undergo dif-
ferentiation and chemotaxis but failed to engraft. Interest-
ingly, if deleted after engraftment Gas deficiency did not
affect HSPCs retention but impaired cytokine-induced mo-
bilization in the blood. In keeping with the notion that acti-
vation of CFTR is accomplished by cAMP-mediated
phosphorylation of its regulatory domain [69], this latest
report would warrant further investigation on the role of
CFTR in the stem cell biology.
The occurrence of an active CFTR to such degree in HSPCs
makes them potentially suitable for the treatment of the CF
lung disease by means of BM transplantation. It might well
be that the functional heterogeneity of subpopulations
identified in this work is reflected also by the different ca-
pacity of progenitor/stem cells to home to epithelia-lined
organs and transform into epithelial cells, as it has been
previously demonstrated [65]. It will undoubtedly be inter-
esting to see which of the 2 subpopulations is the more ef-
ficient in this setup.
While BM transplantation remains a possible future
treatment modality for CF, there are major impediments to
its widespread use, namely, the complications of heter-
ologous transplant, the low engraftment rate of HSPCs, and
the small change in functional CFTR in the lungs. At the
same, other potential cures appear to be closer to clinical use
then gene or cell therapy. Three drug-based approaches are
supposed to give clinical benefit and are being validated in
ongoing clinical trials [70]: (i) correctors, which are com-
pounds that promote trafficking of the mutant CFTR to the
membrane; (ii) potentiators, which promote activity of an
already CFTR inserted in the membrane; (iii) agonists of
P2Y(2) receptors that activated alternative chloride channels
by increasing calcium.
In conclusion, these results show that BM-derived stem/
progenitor cells do not have a homogeneous mitochondrial
content, which may influence their capacity to migrate to a
damaged tissue. CFTR function in these cells is dependent
on mitochondrial ATP synthesis, and CFTR protein is ex-
pressed at a higher level by less primitive cells. Although
CFTR may be envisioned as a HSPC differentiation marker,
further studies will elucidate how CFTR expression is re-
lated to the differentiation state and energetic metabolism
in HSPCs.
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